192 related articles for article (PubMed ID: 22430192)
21. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
22. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
23. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
24. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
[No Abstract] [Full Text] [Related]
25. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
26. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.
Chen K; Zhang H; Zhang LN; Ju SQ; Qi J; Huang DF; Li F; Wei Q; Zhang J
World J Gastroenterol; 2013 May; 19(20):3143-9. PubMed ID: 23716996
[TBL] [Abstract][Full Text] [Related]
27. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
28. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
29. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis.
Tomiya T; Fujiwara K
Cancer; 1996 Mar; 77(6):1056-60. PubMed ID: 8635123
[TBL] [Abstract][Full Text] [Related]
30. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
[TBL] [Abstract][Full Text] [Related]
31. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
Hussein TD
Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
Ibrahim GH; Mahmoud MA; Aly NM
Mol Biol Rep; 2013 Dec; 40(12):7069-75. PubMed ID: 24186850
[TBL] [Abstract][Full Text] [Related]
33. Urinary transforming growth factor-beta 1 in relation to serum alpha-fetoprotein in hepatocellular carcinoma.
Tsai JF; Jeng JE; Chuang LY; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Scand J Gastroenterol; 1997 Mar; 32(3):254-60. PubMed ID: 9085463
[TBL] [Abstract][Full Text] [Related]
34. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.
Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K
World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352
[TBL] [Abstract][Full Text] [Related]
35. Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Abdel-Aziz MM; Elshal MF; Abass AT; El-Kafrawy S; Ezzat S; Abdel-Wahab M
Clin Lab; 2016; 62(6):1121-9. PubMed ID: 27468575
[TBL] [Abstract][Full Text] [Related]
36. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
Hussein MM; Ibrahim AA; Abdella HM; Montasser IF; Hassan MI
Indian J Cancer; 2008; 45(4):167-72. PubMed ID: 19112206
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Jirun P; Zhang G; Kim HK; Ha SA; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Yoo J; Kim S; Park YG; Wang J; Yang Y; Xu Z; Huang Z; Lee YK; Song EY; Kim JW
Dis Markers; 2011; 30(6):307-15. PubMed ID: 21725159
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
